MoneyWorks4Me

PMDA completes inspection of SMS Pharmaceuticals’ manufacturing facility at Telangana

23 Aug 2017 Evaluate

SMS Pharmaceuticals’ manufacturing facility-Unit II located at Bachupally, Ranga Reddy District, Hyderabad, Telangana, India was successfully inspected by Pharmaceuticals and Medical Devices Agency (PMDA), Japan Authorities. The inspection was carried out between July 25, 2017 to July 27, 2017.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..